Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. reports developments tied to disinfection and decontamination products built around SteraMist iHP and Binary Ionization Technology. Company news commonly covers biocidal regulatory approvals, SteraMist applications in healthcare, life sciences, food safety, commercial facilities, transportation and remediation settings, and product categories such as BIT Solution consumables, integrated systems, mobile equipment and iHP Corporate Service offerings.
Updates also include operating and financial results, customer and service activity, training and application protocols, shareholder voting matters, governance topics, capital-structure disclosures and material agreements. TOMI's recurring business themes include the installed base for SteraMist delivery systems, consumable BIT Solution demand, engineered decontamination systems and professional decontamination services.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has announced that NHS Wales has purchased their SteraMist ionized Hydrogen Peroxide (iHP) technology, marking a significant step in expanding their footprint in Great Britain. The NHS Wales aims to enhance its aseptic pharmaceutical manufacturing capabilities, finding traditional cleaning methods cumbersome for large facilities. The purchase includes a SteraMist Environment System, which NHS Wales reported will improve the quality of medicines supplied to patients. TOMI continues to grow its international partnerships, with purchases from various countries, making its SteraMist solutions accessible globally.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported its financial results for Q3 and nine months ending September 30, 2022. Customer sales orders grew by 25% year-over-year, reaching $7.9 million. Despite a sequential revenue drop to $1.76 million, gross margin improved to 60.9%. The operating loss decreased by 24% compared to Q2 2022, reflecting a reduction in operating expenses by 16%. The company anticipates converting a backlog of $2.66 million into revenue. CEO Dr. Halden Shane emphasized a robust sales pipeline heading into 2023.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced it will release its third-quarter results on November 10, 2022, after market close, followed by a conference call at 4:30 p.m. ET. Participants can join the call via a dedicated phone line or through a live webcast, accessible on the company's investor relations page. A replay will be available until November 24, 2022. TOMI specializes in disinfection technologies, particularly its Binary Ionization Technology (BIT™), aimed at diverse sectors including healthcare and food processing.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the purchase of SteraMist disinfection systems by the U.S. Department of Health and Human Services for its Biosafety Level 3 laboratory in Africa. This order includes two SteraPak systems and two Select Surface Units, expanding the NIH's deployment of SteraMist to 30 machines across 11 divisions. SteraMist's technology features a low concentration of hydrogen peroxide, enabling effective disinfection while minimizing equipment corrosion. The COO stated their commitment to supporting NIH's mission with innovative solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a significant $280,000 purchase order from Critical Scientific Solutions for three modified SteraMist Environment Systems. These systems will be utilized by a leading influenza vaccine company for decontamination of cleanrooms and ductwork. The partnership has proven effective since its inception, gaining traction in Australia and New Zealand. TOMI's COO expressed optimism regarding future opportunities in the Life Science sector, emphasizing strong demand for their custom engineered systems.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has received a purchase order for an iHP Custom Engineered System from Avid Bioservices for a new viral vector manufacturing facility in Costa Mesa, California. This system will be implemented in four GMP manufacturing suites and will include eleven applicators. SteraMist was selected due to its rapid decontamination capabilities and low hydrogen peroxide content. The installation is expected to be completed in the first half of 2023, marking a significant step in TOMI's collaboration with Avid, emphasizing the effectiveness of SteraMist technology in the growing cell and gene therapy market.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced the expanding use of its SteraMist decontamination products by a major U.S. pharmaceutical company. Initially adopted five years ago for small spaces, the company has progressively ordered more units, including mobile systems and full-room foggers, totaling around $1 million in expected revenue. Starting in 2023, these systems are projected to generate an annual revenue of approximately $250,000. TOMI's reputation as a disinfection standard continues to grow in the life sciences sector amid increasing investments in safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) specializes in disinfection technology and will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. Dr. Halden Shane, CEO, will present virtually, with the pre-recorded presentation available on September 12. Investors can register for access via the provided link. TOMI's innovative products utilize Binary Ionization Technology to provide effective disinfection solutions across various sectors, including healthcare, education, and military facilities.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported its financial results for Q2 and the first half of 2022, highlighting a 6% revenue growth year-over-year. The company saw a significant 35% increase in customer orders and secured $5.6 million in orders from Fortune 500 clients. While Q2 revenues were flat at $1.458 million, operating loss decreased by 28% to $863,000 due to effective expense management. The gross margin remained strong at 63.2%. TOMI expects revenue recognition from key orders throughout the year, driven by demand for its Custom Engineered Systems.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) will report its second-quarter results for the period ending June 30, 2022, on August 15, 2022, post-market close. A conference call is scheduled for 4:30 p.m. ET on the same day, accessible by phone or via live webcast. TOMI specializes in disinfection and decontamination solutions, leveraging its Binary Ionization Technology (BIT™) to service various sectors, including healthcare and food processing. Replay options for the teleconference and webcast will be available afterward.